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Abstract
Background—We hypothesized that serum magnesium (Mg) is associated with increased risk of
sudden cardiac death (SCD).
Methods—The Atherosclerosis Risk in Communities (ARIC) Study assessed risk factors and levels
of serum Mg in a cohort of 45–64 year olds in 1987–1989 (n = 14,232). After an average of 12 years
of follow-up we observed 264 cases of SCD, as determined by physician review of all suspected
cases. We used proportional hazards regression to evaluate the association of serum Mg with risk of
SCD.
Results—Individuals in the highest quartile of serum Mg were at significantly lower risk of SCD
in all models. This association persisted after adjustment for potential confounding variables, with
an almost 40% reduced risk of SCD (HR=0.62, 95% CI=0.42–0.93) in quartile 4 vs. 1 of serum Mg
observed in the fully-adjusted model.
Conclusions—This study suggests that low levels of serum Mg may be an important predictor of
SCD, and warrants further research into the effectiveness of Mg supplementation for those considered
to be at high risk for SCD.
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Introduction
Sudden cardiac death (SCD) is a major public health problem comprising more than half of all
cardiovascular disease (CVD) deaths in the USA. 1 Even with estimates of coronary heart
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disease (CHD) mortality declining by more than 50% from 1950 to 1999, the relative proportion
of SCD of all CVD deaths in the USA simultaneously increased during this time. 1, 2 Secular
trends in Olmsted County, Minnesota from 1979 to 2003 have shown much larger declines in
in-hospital death rates, with declines in out-of-hospital death rates occurring much more
slowly. 3 Major risk factors for SCD include hypertension, diabetes, smoking, family history
of myocardial infarction, and obesity, but the majority of SCDs occur in those with no prior
history of CVD.4
Magnesium (Mg), a micronutrient and common cation in the human body, is a natural calcium
antagonist and modulates vasomotor tone, blood pressure, and peripheral blood flow. Though
virtually all Mg is stored in cells, low levels of serum Mg are usually predictive of low levels
of total body Mg as well.5 Previous epidemiological studies have reported that serum and
dietary Mg are associated inversely with CVD risk factors such as hypertension,6,7 type 2
diabetes mellitus, 8 the metabolic syndrome, 9 in addition to CHD.10,11 Additional evidence
from ecologic, clinical, and autopsy studies has shown higher Mg to be potentially protective
against SCD,12,13 but no prospective studies have reported the association of Mg levels with
incidence of SCD in the general population. In addition to its role in the regulation of blood
pressure and maintenance of vascular smooth muscle tone, Mg deficiencies are known to cause
ventricular arrhythmias, the most common precursors to SCD. 12,14 Serum Mg levels are
modified by intake of dietary Mg, calcium (Ca) and potassium (K), in addition to alcohol intake
and physical exercise. 15,16
Previous studies in the Atherosclerosis Risk in Communities (ARIC) cohort have shown that
serum Mg levels are associated inversely with incidence of hypertension, 9 CHD,10,11 and
diabetes. 8 In three of these studies,8–10 there were no associations between dietary Mg as
measured from a food frequency questionnaire and these outcomes. The current study was
conducted to assess the relative contribution of serum Mg and dietary Mg intake to the
incidence of SCD.
Research Design and Methods
Study Population
The ARIC Study 17 is a multicenter prospective cohort study investigating the etiology of
atherosclerotic disease in a middle-aged biracial population. One aspect of the study includes
a 1987–89 baseline examination and follow-up of population-based cohorts of 45–64 year olds
from Forsyth County, NC; Jackson, MS (African-Americans only); the northwest suburbs of
Minneapolis, MN; and Washington County, MD.
The ARIC Study protocol was approved by the institutional review board of each participating
university. After obtaining written informed consent, participants underwent a baseline clinical
examination (visit 1). Approximately 46% of those eligible in Jackson and 65% in the other
three communities completed visit 1, yielding a total of 15,792 participants. Participants were
re-examined in 1990–92 (94% return rate), 1993–95 (86%), and 1996–98 (80%). Response to
annual telephone interviews has been 93% of cohort survivors.
Risk Factor Measurements
Most SCD risk factors examined in this analysis were ascertained at the baseline examination.
Participants were asked to fast for twelve hours prior to the clinic exam. Blood was drawn from
an antecubital vein of seated participants into vacuum tubes containing
ethylenediaminetetraacetic acid (for measurement of lipids) or a serum separator gel (Mg, K,
and glucose). Aliquots were stored at −70°C and were shipped to central laboratories for
analyses. The measurement of serum Mg was performed at visits 1 and 2 and was based on the
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procedure of Gindler and Heth using the metallochromic dye, Calmagite (1-(1-hydroxy-4-
methyl-2-phenylazo)-2-napthol-4sulfonic acid). Serum K was measured on a Coulter DACOS
analyzer (Coulter Instruments, Hialeah, FL) using a direct ion-selective electrode. The
laboratory coefficient of variation for Mg, based on split samples sent 1 week apart blindly to
the laboratory, was 3%, 17 and repeated testing of 40 individuals over several weeks yielded a
reliability coefficient of 0.69 for Mg and 0.66 for K. 18 The correlation coefficient of serum
Mg measured at visit 1 versus visit 2 was 0.46. Serum glucose was assayed by a hexokinase/
glucose-6-phosphate dehydrogenase method. Prevalent diabetes mellitus was defined as a
fasting glucose ≥ 126 mg/dl, non-fasting glucose ≥ 200 mg/dl, a self-reported physician
diagnosis, or current treatment for diabetes. Prevalent hypertension was defined as resting
systolic blood pressure ≥ 140 mm Hg, diastolic blood pressure ≥ 90 mm Hg, or current
hypertension treatment.
Questionnaires assessed education, smoking status, number of cigarettes smoked per day and
duration of smoking (pack years computed), and usual alcohol consumption (grams per week
computed). Level of sports physical activity was assessed by the Baecke Questionnaire. 19
Usual dietary intake over the last year was collected using an adapted version of Willett’s 61-
item food frequency questionnaire. 20 Dietary Mg intake was computed by multiplying the Mg
content of each food item by the frequency of its daily consumption and summing over all
items. All medications used in the two weeks before each clinic visit were recorded from bottles
brought by the participant.
Participants underwent a standard supine digitally recorded 12-lead electrocardiogram at rest,
≥1 hour after smoking or caffeine ingestion. Computer analysis at the ARIC ECG Reading
Center included measurement of the voltage and duration of the ECG waves and ECG
classification according to the Minnesota Code. 21,22 In those free of Minnesota codes for
conduction defects (right or left bundle branch block, or intraventricular conduction defect),
the QT interval duration was computed and corrected by Bazett’s formula 23,24: QTcorrected
= QT/√ (heart rate standard/heart rate). The standard heart rate used was 60 beats/min.
Follow-up and Sudden Cardiac Death Definition
All participants were contacted annually by phone and all hospitalizations and deaths in the
previous year were identified. Hospitalizations related to potential myocardial infarctions (MI)
or coronary deaths were abstracted by trained nurses. For deaths, we obtained death certificates.
If the death occurred out-of-hospital, we also sought next of kin interviews and physician,
coroner, and autopsy information about the death. Events were classified as definite, probable,
possible, or no MI, and if fatal, as definite fatal MI, definite fatal CHD, possible fatal CHD, or
non-CHD death. Incident CHD was defined for analysis as definite or probable MI or definite
fatal CHD.
To classify sudden cardiac death (SCD), all events classified as having fatal CHD (definite
fatal MI, definite fatal CHD, or possible fatal CHD, in- and out-of-hospital) were reviewed
again and adjudicated by a committee of physicians, funded through the Johns Hopkins
University Donald W. Reynolds Cardiovascular Research Center. SCD was defined as a sudden
pulseless condition from a cardiac origin in a previously stable individual. After review of data
available, cases were classified as either definite sudden arrhythmic death, possible sudden
arrhythmic death, not sudden arrhythmic death, or unclassifiable. For this analysis, SCD was
defined as the first two categories above. Reviewers were blinded to serum Mg status.
Data Analysis and Statistical Methods
We hypothesized that serum Mg is inversely associated with incidence of SCD. From the
original ARIC cohort (n = 15,792), we excluded participants in very small minority groups
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(n = 103), those missing baseline serum Mg measurements (n = 149), those not fasting at least
8 hours for the baseline examination (n = 550), and those missing covariates (n = 758). This
left 14,232 in the cohort at risk.
Analyses were conducted using SAS software (v. 9.1; SAS Institute, Inc., Cary, NC). To
explore possible confounding factors of associations between Mg and SCD, means or
prevalences of risk factors were computed by quartile of serum Mg using ANOVA. An
individual’s quartile rank was based on up to two serum Mg measurements (visits 1 and 2).
Those individuals who were censored before or did not attend visit 2 were ranked using their
single visit 1 serum Mg measurement. Those individuals who attended visit 2 and were
censored after that visit were ranked using the mean value of their two measurements.
Person-years at risk were calculated from the date of baseline clinical examination until the
date of sudden cardiac death, other death, loss to follow-up, or 31 May 2001, whichever
occurred first. Crude SCD rates (per 1000 person-years) were calculated for quartiles of serum
Mg. Adjusted hazard ratios (HRs) for the association of serum Mg with SCD were calculated
by using Cox proportional hazards regression. Model 1 included adjustment for baseline age,
sex, race and ARIC field center. Adjustment for continuous measures of HDL-c, LDL-c,
triglycerides, serum K, heart rate-adjusted QT-interval, physical activity score, weekly alcohol
intake, and pack years of smoking in addition to baseline smoking status (yes, no), and
education level (< high school, ≥high school) were added to Model 2. The final model included
adjustment for diabetes, hypertension, and use of diuretics (yes, no), modeled as time-varying
covariates with the status at the last visit before death or censoring compared to that of all other
participants still at risk. The test for linear trend in HRs modeled each quartile group as equally-
spaced categories. The proportional hazards assumption of the Cox model was found not to be
violated by testing an interaction between quartiles of serum Mg and time.
We also analyzed the association of SCD with dietary Mg. All diet models were adjusted for
total energy intake, and the final model included dietary covariates highly correlated with Mg:
K, Ca, dietary fiber, protein, caffeine (all measured continuously), and polyunsaturated to
saturated fat ratio.
The ARIC Study is supported by National Heart, Lung, and Blood Institute contracts N01-
HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-
HC-55021, and N01-HC-55022, and the Johns Hopkins University Donald W. Reynolds
Cardiovascular Research Center. The authors are solely responsible for the design and conduct
of this study, all study analyses, the drafting and editing of the article, and its final contents.
Results
The cohort at risk for SCD included 7,887 women and 6,345 men aged 45–64 years at baseline.
Serum Mg levels measured at visits 1 and 2 ranged from 0.4 to 3.1 mEq/L and appeared to be
normally distributed, with 98% of individuals from 1.2 to 2.0 mEq/L. As table 1 shows, LDL-
c and HDL-c, heart rate-adjusted QT interval, serum K, physical activity, education, and dietary
Mg intake were all associated positively with levels of serum Mg. Fasting triglycerides, pack-
years of smoking, systolic blood pressure, hypertension, diabetes, use of diuretics, female sex,
being African-American, and education were associated inversely with serum Mg. There were
no differences in the percentage of current or former smokers, mean weekly alcohol intake, or
daily total energy intake by quartile of serum Mg.
Through May 31, 2001, 264 individuals were classified as having died from either definite
(n=217) or possible (n=47) SCD. There were 46 events in Forsyth County, 93 in Jackson, 48
in Minneapolis, and 77 in Washington County. Table 2 shows that the age-, race-, sex-, and
field center-adjusted risk of SCD was inversely associated with serum Mg (p for linear trend
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<0.0001). Compared to the lowest quartile of Mg, the risk of SCD was 55% lower (HR=0.45,
95% C.I., 0.31–0.67) in the highest Mg quartile and 47% lower in the second highest quartile
(HR=0.53, 95% C.I., 0.38–0.74). This strong association persisted after adjustment for
potentially confounding variables, including baseline measures of fasting lipids, heart rate
adjusted-QT interval, serum K, physical activity score, smoking status and pack years, regular
alcohol intake, and education level (Model 2) (p for linear trend = 0.0006), but point estimates
of the association were attenuated modestly (HR = 0.55 for quartile 4 vs. 1, 95% C.I. = 0.37–
0.83; and HR = 0.62 for quartile 3 vs. 1, 95% C.I. = 0.44–0.88). Apart from lower Mg, only
greater age, male sex, being African-American, not being at the Forsyth County field center,
lower HDL, higher LDL, greater pack-years of smoking, and less education were associated
with greater risk of SCD in Model 2.
After further adjustment for prevalent diabetes, prevalent hypertension, and use of diuretics
(Model 3), each associated with greater risk of SCD, the serum Mg association was attenuated
slightly (p for linear trend = 0.006), with both quartiles 4 (HR = 0.62, 95% C.I. = 0.42–0.93)
and 3 (HR = 0.70, 95% C.I. = 0.49–0.99) at significantly reduced risk of SCD when compared
to the lowest quartile of serum Mg. Restriction of this analysis to only definite cases of SCD
(n=217) attenuated these results, with quartile 4 (HR = 0.72, 95% C.I. = 0.46–1.11) no longer
associated with a reduced risk of SCD (data not shown).
In order to assess the specificity of this association, we restricted the definition of SCD in three
ways: cases that were 1) unwitnessed, 2) determined to have taken place outside of the hospital,
or 3) determined to not be associated with MI by the physician reviewers (Table 2 bottom).
The risk of unwitnessed SCD in the fully-adjusted model was marginally lower than for all
SCD cases for quartile 4 compared to quartile 1 (HR = 0.49, 95% C.I. = 0.25–0.99), but the
linear trend was no longer significant (p = 0.07). Restricting the SCD cases to out-of-hospital
events did not change the overall association. The serum Mg association with SCD was
somewhat stronger for cases not associated with MI, with quartile 4 (HR = 0.51, 95% C.I. =
0.32–0.83) at one-half the risk of death as the lowest quartile, greatly excluding the null.
To explore potential effect modification by prevalent CHD, we redid the analysis several
different ways. Additional analyses which excluded prevalent CHD cases at baseline and
censored individuals at the time of an incident non-fatal event (definite or possible MI, ECG-
detected silent MI between examinations, coronary revascularization), reducing the number of
cases by about half, showed similar, albeit weaker, results with wide confidence intervals
including the null. Alternatively, adjusting for incident CHD occurrence before SCD by
modeling it as a time-dependent covariate attenuated the association, with quartile 4 (HR =
0.69, 95% C.I. = 0.46–1.04), no longer significantly associated with a reduced risk of SCD.
There was no evidence of effect modification by prevalent or incident CHD on the association
of serum Mg with SCD. None of the two-way interactions of sex, race, heart rate-adjusted QT
interval, serum K, and diuretic use with serum Mg was statistically significant at p<0.05.
Figure 1 illustrates the pattern of risk in those individuals who had serum Mg measured at both
clinic examinations (n=13,010 at risk, 194 cases). For this figure, the cohort was dichotomized
at the median value of both measurements of serum Mg, thereby comparing the upper two
quartiles vs. lower two. Compared to those with Mg < median at both visits, individuals with
serum Mg above the median at only one visit were not at a different risk of SCD. However,
the risk of SCD was 42% lower in those individuals with serum Mg above the median at both
visits (HR = 0.58, 95% C.I. = 0.37–0.89).
We also compared this association to that of serum Mg with CHD deaths not classified as
definite or possible SCD. Over the same time period, 868 individuals were classified as having
died from CHD, but not SCD. In all three models, the association was present, but attenuated
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compared with the association of Mg level with SCD (Model 3 HR = 0.69, 95% C.I. = 0.56–
0.84). Similar analyses were performed with dietary Mg as the exposure of interest. There was
no evidence of an association between dietary Mg intake and risk of SCD in any of the models
described above (data not shown).
Discussion
The main finding from this analysis was a significantly reduced risk of SCD in the highest
quartile compared to the lowest quartile of serum Mg in a prospective cohort with over 173,000
person years of follow-up. This association persisted after adjustment for the major predictors
of SCD and potential confounders (or mediators) of the Mg – SCD relationship, including
hypertension, diabetes, serum K, heart-rate adjusted QT interval, and use of diuretics. The
association was monotonic with a declining risk of SCD with each quartile of higher serum
Mg. This association did not differ by race, sex, prevalent CHD, use of diuretics, serum K
level, or heart-rate adjusted QT interval. Despite these strong findings for serum Mg, we
observed no association between dietary Mg and risk of SCD. This is not surprising given
previous reports from this cohort showing no association of dietary Mg with either incident
hypertension or CHD, despite associations of these outcomes with serum Mg. 9,10
The reliability coefficient for serum Mg was moderate at 0.69, 18 but we were still able to detect
a strong association between low serum Mg and risk of SCD. Individuals who maintained
serum Mg levels above the median value at two visits 3 years apart had the lowest risk of SCD.
Nevertheless, a limitation of our study was an inability to assess levels of serum Mg just prior
to an event. It could be that a sudden drop in Mg is important. However, measurement just
before SCD is not possible in a prospective study. Serial measurements of serum Mg over
many years would improve our ability to understand the impact of short-term transient changes
in serum Mg on the risk of SCD.
The final model included adjustment for important predictors of SCD that may or may not be
on the causal pathway of the Mg/SCD association. Hypertension is a known risk factor for
SCD, 4,25,26 and a previous analysis in this population showed a modest association of low
serum Mg with incident hypertension.7 It is unclear to what degree depleted Mg affects risk
of SCD through its influence on blood pressure and risk of hypertension, but it seems unlikely
that this is a major pathway given that adjustment had little impact on risk estimates.
Prescription of diuretics for hypertension presents an unusual circumstance whereby the
medication use clearly reduces blood pressure at the same time it leads to excessive Mg loss
through urinary excretion. 12,27 Previous case-control studies have shown an increased odds
of SCD in patients taking non-potassium-sparing diuretics. 28,29 Recent large clinical trials
have not clearly shown diuretics to affect risk of death and cardiovascular events differently
from beta blockers and ACE inhibitors. 30,31
Low serum Mg is often observed in conjunction with low serum K, and low levels of both
micronutrients have been implicated in ECG changes, including a shortening of the QT interval.
32,33 In addition, serum Mg deficiency has been shown to lead to ventricular arrhythmias, the
most common precursor to SCD. 12 In the multivariable-adjusted models, there was no
association of serum K or heart rate-adjusted QT interval with SCD. At least one study has
shown that Mg may serve to block the short-term increase in intracellular calcium during
myocardial ischemia, another precursor to arrhythmia. 15,34 The addition of these variables to
the models had little influence on the HRs of SCD by quartile of serum Mg, suggesting an
independent pathway whereby Mg influences risk of SCD.
Several studies have shown that serum Mg deficiency is frequently detected in patients who
have survived an MI. 13 Mg therapy during and after an MI has been shown to reduce the
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occurrence of ventricular arrhythmias, 13,14 and improve survival, in some, but not all studies.
14,15,36–39 In addition, autopsy studies have shown Mg in myocardial tissue of SCD cases is
lower than in those dying of other causes. 13 Whether these lower levels of Mg are a cause or
result of SCD remain unknown. Low levels of serum Mg in the normal range, such as in this
study, may predispose individuals to serum Mg deficiency that could be detected with serial
measurements. Additional prospective studies with more frequent measurements of serum Mg
would help address this question. Despite the positive results on the prevention of secondary
events with Mg therapy, no clinical trials on the efficacy of Mg supplementation on the primary
prevention of SCD have been conducted.
In summary, this analysis is the first to demonstrate a significantly higher risk of SCD in
individuals in the lowest quartile of the normal physiologic range of serum Mg compared to
those in the highest quartile. This association is independent of other risk factors for SCD with
only marginal attenuation of the association after full adjustment for all known potential
predictors. There is a similar, albeit weaker, increased risk of non-sudden CHD death in
individuals with low levels of serum Mg. The association reported here is moderately strong,
and potentially modifiable. It becomes stronger in SCD cases that are unrelated to MI. A better
understanding of the causal mechanism will require more detailed studies of temporal changes
in serum Mg levels just before SCD and related events. Replication of these findings in other
populations and additional research into the causal mechanism is warranted. If the association
is consistent and replicated across other studies, it may warrant the initiation of clinical trials
to evaluate the impact of targeted Mg supplementation in individuals at higher risk for SCD.
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Figure 1. Adjusted* hazard ratios (95% CI) of definite or possible Sudden Cardiac Death by
categories of serum Magnesium at two ARIC visits
* Adjusted for age, race, sex, field center, HDL, LDL, TG, BMI, serum K, heart rate-adjusted
QT interval, physical activity, current smoking, pack years, ETOH intake, education, prevalent
diabetes, hypertension, and diuretics use
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